Cargando…
Antileishmanial Aminopyrazoles: Studies into Mechanisms and Stability of Experimental Drug Resistance
Current antileishmanial treatment is hampered by limitations, such as drug toxicity and the risk of treatment failure, which may be related to parasitic drug resistance. Given the urgent need for novel drugs, the Drugs for Neglected Diseases initiative (DNDi) has undertaken a drug discovery program,...
Autores principales: | Van den Kerkhof, M., Mabille, D., Hendrickx, S., Leprohon, P., Mowbray, C. E., Braillard, S., Ouellette, M., Maes, L., Caljon, G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449183/ https://www.ncbi.nlm.nih.gov/pubmed/32601168 http://dx.doi.org/10.1128/AAC.00152-20 |
Ejemplares similares
-
In vitro and in vivo pharmacodynamics of three novel antileishmanial lead series
por: Van den Kerkhof, M., et al.
Publicado: (2018) -
Identification of Resistance Determinants for a Promising Antileishmanial Oxaborole Series
por: Van den Kerkhof, Magali, et al.
Publicado: (2021) -
Chemogenomic Profiling of Antileishmanial Efficacy and Resistance in the Related Kinetoplastid Parasite Trypanosoma brucei
por: Collett, Clare F., et al.
Publicado: (2019) -
RNA Sequencing Elucidates Drug-Specific Mechanisms of Antibiotic Tolerance and Resistance in Mycobacterium abscessus
por: Schildkraut, Jodie A., et al.
Publicado: (2022) -
What Is Resistance? Impact of Phenotypic versus Molecular Drug Resistance Testing on Therapy for Multi- and Extensively Drug-Resistant Tuberculosis
por: Heyckendorf, Jan, et al.
Publicado: (2018)